Proc Natl Acad Sci USA 97 , 46094614 (2000)
The authors themselves described it as a small preliminary study.[15] A 2025 pilot report described intravenous administration to two healthy adults at doses up to 20 mg, with no measurable changes in cardiac, hepatic, renal or thyroid biomarkers and no reported adverse effects.[16] Two individuals cannot characterise uncommon reactions, immunogenicity, long-term toxicity, reproductive safety or oncological risk
Keep them away from light exposure
MELANOTAN II PEPTIDE 10MG LIQUID SPRAY 15ML BOTTLE (100MCG/SPRAY, 10MG TOTAL) 0 out of 5 $65.99 Melanotan II is sold for laboratory research use only
Common, mild effects: Temporary soreness or redness at the injection site
when they get too short, cells stop dividing and aging accelerates